These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 20635830)
1. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy. Gören JL; Beck SE; Mills BJ; Shtasel DL; Dufresne RL J Manag Care Pharm; 2010; 16(6):393-401. PubMed ID: 20635830 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points. McMillan SS; Jacobs S; Wilson L; Theodoros T; Robinson G; Anderson C; Mihala G; Wheeler AJ BMC Psychiatry; 2017 Apr; 17(1):139. PubMed ID: 28407747 [TBL] [Abstract][Full Text] [Related]
3. Antipsychotic polytherapy on an inpatient psychiatric unit: how does clinical practice coincide with Joint Commission guidelines? Huffman JC; Chang TE; Durham LE; Weiss AP Gen Hosp Psychiatry; 2011; 33(5):501-8. PubMed ID: 21762994 [TBL] [Abstract][Full Text] [Related]
4. Audit of antipsychotic prescribing in a private psychiatric hospital. Botvinik L; Ng C; Schweitzer I Australas Psychiatry; 2004 Sep; 12(3):227-33. PubMed ID: 15715780 [TBL] [Abstract][Full Text] [Related]
5. Improving the success of mailed letter intervention programs to influence prescribing behaviors: a review. Ho MJ; Venci J J Manag Care Pharm; 2012 Oct; 18(8):627-49. PubMed ID: 23127150 [TBL] [Abstract][Full Text] [Related]
6. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages. Kogut SJ; Yam F; Dufresne R J Manag Care Pharm; 2005; 11(1):17-24. PubMed ID: 15667230 [TBL] [Abstract][Full Text] [Related]
7. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study. Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization. Saldaña SN; Keeshin BR; Wehry AM; Blom TJ; Sorter MT; DelBello MP; Strawn JR Pharmacotherapy; 2014 Aug; 34(8):836-44. PubMed ID: 24990538 [TBL] [Abstract][Full Text] [Related]
9. The Additional Effect of Individualized Prescriber-Focused Feedback on General Guideline Instruction in Reducing Antipsychotic Polypharmacy in Inpatients. Lochmann van Bennekom MWH; Gijsman HJ; Groenewoud H; Verkes RJ J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):129-134. PubMed ID: 33666400 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of antipsychotic polypharmacy in schizophrenic patients discharged from psychiatric units in Poland. Jaracz J; Tetera-Rudnicka E; Kujath D; Raczyńska A; Stoszek S; Czernaś W; Wierzbiński P; Moniakowski A; Jaracz K; Rybakowski J Pharmacol Rep; 2014 Aug; 66(4):613-7. PubMed ID: 24948062 [TBL] [Abstract][Full Text] [Related]
11. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals]. Bret P; Bret MC; Queuille E Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381 [TBL] [Abstract][Full Text] [Related]
12. Use of Academic Detailing With Audit and Feedback to Improve Antipsychotic Pharmacotherapy. Brunette MF; Cotes RO; de Nesnera A; McHugo G; Dzebisashvili N; Xie H; Bartels SJ Psychiatr Serv; 2018 Sep; 69(9):1021-1028. PubMed ID: 29879874 [TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Quality of prescribing of antipsychotic medication for people with intellectual disability under the care of UK mental health services: a cross-sectional audit of clinical practice. Paton C; Bhatti S; Purandare K; Roy A; Barnes T BMJ Open; 2016 Dec; 6(12):e013116. PubMed ID: 27920085 [TBL] [Abstract][Full Text] [Related]
15. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
16. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics. Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211 [TBL] [Abstract][Full Text] [Related]
17. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. Kroken RA; Johnsen E; Ruud T; Wentzel-Larsen T; Jørgensen HA BMC Psychiatry; 2009 May; 9():24. PubMed ID: 19445700 [TBL] [Abstract][Full Text] [Related]
19. Use of antipsychotic and antidepressant within the Psychiatric Disease Centre, Regional Health Service of Ferrara. Bianchi S; Bianchini E; Scanavacca P BMC Clin Pharmacol; 2011 Dec; 11():21. PubMed ID: 22185397 [TBL] [Abstract][Full Text] [Related]
20. Explicit versus implicit review to explore combination antipsychotic prescribing. Wheeler A J Eval Clin Pract; 2009 Aug; 15(4):685-91. PubMed ID: 19674220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]